Sirolimus in combination with tacrolimus or mycophenolate mofetil for minimizing acute rejection risk in renal transplant recipients--a single center experience

Transplant Proc. 2003 May;35(3 Suppl):89S-94S. doi: 10.1016/s0041-1345(03)00220-3.
No abstract available

Publication types

  • Comparative Study

MeSH terms

  • Acute Disease
  • Adult
  • Area Under Curve
  • Child
  • Graft Rejection / prevention & control*
  • Humans
  • Immunosuppressive Agents / pharmacokinetics
  • Immunosuppressive Agents / therapeutic use
  • Kidney Transplantation / immunology*
  • Mycophenolic Acid / analogs & derivatives*
  • Mycophenolic Acid / therapeutic use*
  • New York
  • Retrospective Studies
  • Sirolimus / pharmacokinetics
  • Sirolimus / therapeutic use*
  • Tacrolimus / pharmacokinetics
  • Tacrolimus / therapeutic use*

Substances

  • Immunosuppressive Agents
  • Mycophenolic Acid
  • Sirolimus
  • Tacrolimus